Rafael Morales-Vadillo

Rafael Morales-Vadillo

Auto-generated profile, based on publicly available information

Rafael Morales-Vadillo

University of San Martín de Porres, Peru

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
JGJo. Guevara-Canales
Jo. Guevara-Canales
MGMm. Gutierrez-Morales
Mm. Gutierrez-Morales
SSSj. Sacsaquispe-Contreras
Sj. Sacsaquispe-Contreras
JSJ. Sanchez-Lihon
J. Sanchez-Lihon
RMR. Morales-Vadillo
R. Morales-Vadillo
To determine the epidemiological profile of malignant melanoma cases treated at the National Institute for Neoplastic Diseases "Dr. Eduardo Caceres Graziani" (INEN) over the period 1952 to 2008. All clinical records with complete data of patients presenting a histopathological diagnosis of malignant melanoma of the oral cavity were reviewed. Data such as age, gender, location, tumor size, disease length, presence of metastasis, treatment received and year of admission were recorded. During the study period 97 cases were found. The average age of patients was 52.85±1.6 years old mostly between 50 and 59 years old; the predominant gender was the female. The most common location was the palate and there was 58.8% of cases with a tumor size bigger than or equal to 4 cm. The length of the disease in 38.1% of the cases was longer than a year and in great part of the cases (69.1%) there was no metastasis. The treatment of choice was the surgery plus radiotherapy in 38.1% of the cases. According to the admission date it was also noted that the number of cases is increasing. The results of this study demonstrate a late diagnosis and an increasing frequency of this neoplasia in the oral cavity.

1 January 2013 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
JGJo. Guevara-Canales
Jo. Guevara-Canales
RMR. Morales-Vadillo
R. Morales-Vadillo
SSSj. Sacsaquispe-Contreras
Sj. Sacsaquispe-Contreras
Carlos BarrionuevoCarlos Barrionuevo
Carlos Barrionuevo
JMJ. Montes-Gil
J. Montes-Gil
MCMgam. Chaves
Mgam. Chaves
To identify the overall survival and prognostic factors of malignant lymphoma of the oral cavity and the maxillofacial region. Clinical records data were obtained in order to determine overall survival at 2 and 5 years, the individual survival percentage of each possible prognostic factor with the actuarial technique, and the survival regarding the possible prognostic factors with the actuarial technique and the Log-rank and Cox's regression tests. Of 151 subjects, an overall survival was 60% at 2 years, and 45% at 5 years. The multivariate analysis demonstrated statistically significant differences for clinical stage (p=0.002), extranodal involvement (p=0.030), presence of human immunodeficiency virus (p=0.032), and presence of Epstein-Barr virus (p=0.010). The advanced clinical stage and the larger number of involved extranodular sites are related to a lower overall survival, as well as, the presence of previous infections such as the human immunodeficiency and the Epstein-Barr virus.

29 July 2016 in Journal of Maxillofacial and Oral Surgery
Verified
Journal Article
Closed access
PDF file
GJGuevara-Canales Janet-Ofelia
Guevara-Canales Janet-Ofelia
MRMorales-Vadillo Rafael
Morales-Vadillo Rafael
GGGuzmán-Arias Guillermo
Guzmán-Arias Guillermo
CCCava-Vergiú Carlos-Enrique
Cava-Vergiú Carlos-Enrique
RJRobello-Malatto José-Martín
Robello-Malatto José-Martín
MJMontes-Gil Jaime-Enrique
Montes-Gil Jaime-Enrique

1 January 2012 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
JGJo. Guevara-Canales
Jo. Guevara-Canales
SSSj. Sacsaquispe-Contreras
Sj. Sacsaquispe-Contreras
RMR. Morales-Vadillo
R. Morales-Vadillo
JSJ. Sanchez-Lihon
J. Sanchez-Lihon
Objective: Analysis of the clinical characteristics of patients with Sarcomas of the Jaws treated in the ?Instituto Nacional de Enfermedades Neoplasicas. Dr. Eduardo Caceres Graziani? from 1952-2007. Study Design: Review of 155 clinical records of patients with Sarcomas of the Jaws and record of age, gender, size, location, clinical symptoms and signs, histopathological diagnoses and type of treatment. The data obtained were analyzed by means of Student?s statistical t-test, Fisher and Friedman?s test. Results: Analysis of 155 Sarcomas of the Jaws. The average age of patients was 36.8 years old (range: 1-80 years); the female gender was the most frequent (52.9%); the average tumor size was 5.5 cm; in upper jaw 54.84% occurred and 45.16% in the lower jaw; the predominant sign was facial asymmetry (87.74%) and the predominant symptom: pain (63.23%). The most frequent diagnosis was Osteosarcoma 50.3% followed by Chondrosarcoma 18%. Surgery plus radiation therapy was the treatment type of choice with 21.94% of cases. Conclusion: The results of this study demonstrate the delayed diagnosis and facial asymmetry and pain appear as the most important events for the diagnosis of Sarcomas of the Jaw

1 October 2011 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
RVRafael Morales Vadillo
Rafael Morales Vadillo
SCSonia Julia Sacsaquispe Contreras
Sonia Julia Sacsaquispe Contreras
JCJanet Ofelia Guevara Canales
Janet Ofelia Guevara Canales
The aim of this study was to identify the prognostic factors related to the survival of patients with sarcomas of the jaw treated in the Dr. Eduardo Caceres Graziani National Institute for Neoplastic Diseases, Lima, Peru. Age, gender, delay in consultation, diagnostic delay, therapeutic delay, tumor size, tumor location, facial asymmetry, pain, treatment type, and histopathological diagnosis were all evaluated as possible prognostic factors that would influence survival in those with jaw sarcomas. In the analysis, the following was used: mortality tables, Kaplan-Meier's product-limit method, log-rank, and Breslow and Tarone-Ware tests; for the prognostic factors, Cox's Regression Model was used. The overall survival rate, with the patient being free from disease at two years, was 55%, and that at five years was 45%. In the independent analysis of the prognostic factors, four variables were statistically significant in influencing survival: gender (p = 0.043), histopathologic diagnosis (p = 0.019), tumor location (p = 0.019), and treatment type (p = 0.030). According to Cox's Regression Model for the multivariate analysis, statistically significant prognostic factors were: gender (p = 0.086), tumor location (p = 0.020), and treatment type (p = 0.092). Thus, the variables of gender, tumor location, and treatment type were determined to be predictive factors for prognosis of survival.

11 June 2013 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
JGJanet Ofelia Guevara-Canales
Janet Ofelia Guevara-Canales
RMRafael Morales-Vadillo
Rafael Morales-Vadillo
CCCarlos Enrique Cava-Vergiu
Carlos Enrique Cava-Vergiu
FLFabiola Pessoa Pereira Leite
Fabiola Pessoa Pereira Leite
HNHenrique Duque de Miranda Chaves Netto
Henrique Duque de Miranda Chaves Netto
MCMaria das Gracas Afonso Mirand Chaves
Maria das Gracas Afonso Mirand Chaves
The purpose of this study was to determine the survival and prognostic factors of patients with diffuse large B-cell lymphoma (DLBCL) of the oral cavity and maxillofacial region. Retrospectively, the clinical records of patients with a primary diagnosis of DLBCL of the oral cavity and maxillofacial region treated at the A.C. Camargo Hospital for Cancer, São Paulo, Brazil, between January 1980 and December 2005 were evaluated to determine (A) overall survival (OS) at 2 and 5 years and the individual survival percentage for each possible prognostic factor by means of the actuarial technique (also known as mortality tables), and the Kaplan Meier product limit method (which provided the survival value curves for each possible prognostic factor); (B) prognostic factors subject to univariate evaluation with the log-rank test (also known as Mantel-Cox), and multivariate analysis with Cox's regression model (all the variables together). The data were considered significant at p ≤ 0.05. From 1980 to 2005, 3513 new cases of lymphomas were treated, of which 151 (4.3%) occurred in the oral cavity and maxillofacial region. Of these 151 lesions, 48 were diffuse large B-cell lymphoma, with 64% for OS at 2 years and 45% for OS at 5 years. Of the variables studied as possible prognostic factors, multivariate analysis found the following variables have statistically significant values: age (p = 0.042), clinical stage (p = 0.007) and performance status (p = 0.031). These data suggest that patients have a higher risk of mortality if they are older, at a later clinical stage, and have a higher performance status.